✦ LIBER ✦

Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients

✍ Scribed by T.L. Pruett; R.W. McGory; F.H. Wright; M.D. Pescovitz; H. Yang; J.B. McClain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and immunodynamics of c

✍ J. M. Kovarik; E. Rawlings; P. Sweny; O. Fernando; R. Moore; P. J. Griffin; P. F 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 179 KB

Preclinical pharmacokinetics, pharmacody

✍ Sean K Kelley; Thomas Gelzleichter; Dong Xie; Wyne P Lee; Walter C Darbonne; Fer 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB

Preclinical pharmacokinetics, pharmacody

✍ S K Kelley; T Gelzleichter; D Xie; W P Lee; W C Darbonne; F Qureshi; K Kissler; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

Safety profile of intravenous and subcut

✍ Richard G. Langley; Kim Papp; Robert Bissonnette; Darryl Toth; Robert Matheson; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Pharmacokinetics and pharmacodynamics of

✍ T. Haba; K. Uchida; A. Katayama; Y. Tominaga; T. Sato; I. Watanabe; H. Inagaki; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Safety profile and clinical activity of

✍ Joseph M Parker; Chad K Oh; Craig LaForce; S David Miller; David S Pearlman; Che 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 361 KB